Insider Stock Trading History of Vivo Capital Fund Viii, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Vivo Capital Fund Viii, L.p. since year 2005. The trader's CIK number is 1618788. At the time of this reporting, Vivo Capital Fund Viii, L.p. is the 10% Owner of Menlo Therapeutics, Inc. . (stock ticker symbol MNLO). See this page for all insider trading activities at Menlo Therapeutics, Inc. .

Note that in the past Vivo Capital Fund VIII, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Vivo Capital Fund Viii, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-25 MNLO Menlo Therapeutics, Inc. Buy 294,118 17.00 5,000,006
2017-04-28 BPMX Biopharmx Corp Buy 1,282,052 .78 1,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vivo Capital Fund Viii, L.p. (10% Owner of Menlo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.